Immunomodulatory oligosaccharides for the enhancement of anti-tumor efficacy of immuno-oncology agents
AssigneeIntrinsic Medicine, Inc.
InventorsAlexander Martinez, Jason Ferrone, Emil Chuang
Life of this patent
Estimating the term…
Abstract
The disclosure provides for methods of enhancing anti-tumor therapies with immunomodulatory human milk oligosaccharides.
Claims53
A pharmaceutical composition comprising a human milk oligosaccharide selected from the group consisting of 2′fucosyllactose, 3′ sialyllactose, and 6′ sialyllactose, wherein the composition further comprises an immune checkpoint inhibitor.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method for treating cancer, comprising co-administering an effective amount of a human milk oligosaccharide and an effective amount of one or more immune checkpoint inhibitors to a subject in need thereof.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.